1. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study;Backonja;Pain,1994
2. Ketamine as daily low i.m. and p.o. doses has dramatically reduced a severe case of post-herpetic neuralgia for 5 months, Abstract 512;Borchgrevink,1993
3. Subcutaneous ketamine analgesia: postoperative analgesia using subcutaneous infusions of ketamine and morphine;Bristow;Ann. R. Coll. Surg. Eng.,1989
4. N-methyl-d-aspartate (NMDA) antagonism is central to the actions of ketamine and other phencyclidine receptor ligands;Church,1990
5. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans;Clements;J. Pharm. Sci.,1982